Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP1216210.RAqykt6JenNMvBAY81OeDl2Bs-T9hvJevAFzhcJUU4REk130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP1216210.RAqykt6JenNMvBAY81OeDl2Bs-T9hvJevAFzhcJUU4REk130_assertion type Assertion NP1216210.RAqykt6JenNMvBAY81OeDl2Bs-T9hvJevAFzhcJUU4REk130_head.
- NP1216210.RAqykt6JenNMvBAY81OeDl2Bs-T9hvJevAFzhcJUU4REk130_assertion description "[These findings reveal IL-37 as an important anti-inflammatory modulator during obesity-induced inflammation and insulin resistance in both mice and humans, and suggest that IL-37 is a potential target for the treatment of obesity-induced insulin resistance and type 2 diabetes.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1216210.RAqykt6JenNMvBAY81OeDl2Bs-T9hvJevAFzhcJUU4REk130_provenance.
- NP1216210.RAqykt6JenNMvBAY81OeDl2Bs-T9hvJevAFzhcJUU4REk130_assertion evidence source_evidence_literature NP1216210.RAqykt6JenNMvBAY81OeDl2Bs-T9hvJevAFzhcJUU4REk130_provenance.
- NP1216210.RAqykt6JenNMvBAY81OeDl2Bs-T9hvJevAFzhcJUU4REk130_assertion SIO_000772 25182023 NP1216210.RAqykt6JenNMvBAY81OeDl2Bs-T9hvJevAFzhcJUU4REk130_provenance.
- NP1216210.RAqykt6JenNMvBAY81OeDl2Bs-T9hvJevAFzhcJUU4REk130_assertion wasDerivedFrom befree-2016 NP1216210.RAqykt6JenNMvBAY81OeDl2Bs-T9hvJevAFzhcJUU4REk130_provenance.
- NP1216210.RAqykt6JenNMvBAY81OeDl2Bs-T9hvJevAFzhcJUU4REk130_assertion wasGeneratedBy ECO_0000203 NP1216210.RAqykt6JenNMvBAY81OeDl2Bs-T9hvJevAFzhcJUU4REk130_provenance.